- Tirzepatide demonstrated significant and superior weight loss compared to placebo in two pivotal studies | Eli Lilly and … Investors | Eli Lilly and Company
- Eli Lilly says obesity drug helped boost weight loss to 26%, highest seen in late-stage trials CNBC
- Lilly’s obesity drug leads to about 26% weight loss in new studies Reuters
Brought to you by Google News. Read the rest of the article here